A normal person with a low level of HGH before the test doesn’t necessarily mean that he has a disease. The level of HGH of a patient is bound to increase after simulation. If the level doesn’t increase after simulation, then the patient is recommended for other tests and will be examined for other symptoms of HGH disease.
GHST involves the injection of insulin-induced hypoglycemia or HGH releasing factor to stimulate the secretion of HGH. Blood samples are taken five times after the injection of a stimulant. These blood samples are used in determining the HGH level of a patient.
During the test, a patient may experience sweating and sleepiness. A minor distress is also expected to be felt after the test. There are also cases of ketosis and a disturbance of the body’s acid-base balance that is associated with GHST. A patient may also experience too much bleeding, fainting, blood accumulation under the skin and infection. However, all of these side effects can be avoided with proper and keen observation form the administering doctor.
The GHST is one of the frequently used tests in determining HGH diseases. However, it is merely a test to determine the HGH level and the pituitary gland’s capacity to produce HGH. A fixed HGH level is used as parameter to determine if a patient has HGH deficiency. Normal results vary with sex and age. If a patient falls below the normal results, he is recommended for diagnosis and treatment.
Undergoing a test is not the cure for HGH diseases. The tests are only the start of treating HGH diseases. All people are at risk of acquiring Human growth diseases. People who notice abnormalities in their height or muscle mass should immediately submit themselves for a test. It is never too late to prevent HGH diseases.